Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 9 studies | 38% ± 15% | |
oligodendrocyte | 9 studies | 27% ± 7% | |
glutamatergic neuron | 6 studies | 43% ± 24% | |
endothelial cell | 5 studies | 36% ± 19% | |
microglial cell | 5 studies | 21% ± 5% | |
oligodendrocyte precursor cell | 5 studies | 30% ± 8% | |
macrophage | 5 studies | 20% ± 5% | |
GABAergic neuron | 4 studies | 45% ± 15% | |
interneuron | 4 studies | 39% ± 21% | |
neuron | 3 studies | 29% ± 8% | |
epithelial cell | 3 studies | 24% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 39% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1718.84 | 1443 / 1445 | 100% | 11.98 | 183 / 183 |
brain | 100% | 1952.85 | 2632 / 2642 | 100% | 14.03 | 704 / 705 |
ovary | 100% | 2178.48 | 180 / 180 | 99% | 15.07 | 425 / 430 |
prostate | 100% | 2178.40 | 245 / 245 | 99% | 12.03 | 496 / 502 |
thymus | 100% | 2184.10 | 653 / 653 | 98% | 14.92 | 594 / 605 |
breast | 100% | 1736.19 | 459 / 459 | 97% | 10.30 | 1083 / 1118 |
lung | 100% | 1869.31 | 577 / 578 | 97% | 9.12 | 1118 / 1155 |
kidney | 100% | 1858.17 | 89 / 89 | 96% | 15.81 | 866 / 901 |
pancreas | 99% | 908.19 | 326 / 328 | 96% | 8.86 | 171 / 178 |
adrenal gland | 100% | 1307.27 | 257 / 258 | 94% | 11.33 | 217 / 230 |
stomach | 100% | 2718.12 | 359 / 359 | 93% | 10.42 | 267 / 286 |
bladder | 100% | 2240.38 | 21 / 21 | 89% | 7.95 | 448 / 504 |
skin | 100% | 1806.31 | 1808 / 1809 | 89% | 10.18 | 419 / 472 |
uterus | 100% | 4461.51 | 170 / 170 | 88% | 7.52 | 403 / 459 |
intestine | 100% | 1933.50 | 966 / 966 | 86% | 7.46 | 455 / 527 |
liver | 94% | 531.92 | 212 / 226 | 65% | 4.16 | 264 / 406 |
adipose | 100% | 1946.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2517.98 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1374.17 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 99% | 845.17 | 791 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 979.88 | 818 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 4.64 | 39 / 45 |
lymph node | 0% | 0 | 0 / 0 | 79% | 5.38 | 23 / 29 |
eye | 0% | 0 | 0 / 0 | 57% | 4.14 | 46 / 80 |
peripheral blood | 50% | 433.85 | 463 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030010 | Biological process | establishment of cell polarity |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0035773 | Biological process | insulin secretion involved in cellular response to glucose stimulus |
GO_0045055 | Biological process | regulated exocytosis |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0006909 | Biological process | phagocytosis |
GO_0035669 | Biological process | TRAM-dependent toll-like receptor 4 signaling pathway |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001891 | Cellular component | phagocytic cup |
GO_0042995 | Cellular component | cell projection |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005768 | Cellular component | endosome |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RAB11FIP2 |
Protein name | Rab11 family-interacting protein 2 (Rab11-FIP2) (NRip11) |
Synonyms | KIAA0941 |
Description | FUNCTION: A Rab11 effector binding preferentially phosphatidylinositol 3,4,5-trisphosphate (PtdInsP3) and phosphatidic acid (PA) and acting in the regulation of the transport of vesicles from the endosomal recycling compartment (ERC) to the plasma membrane. Involved in insulin granule exocytosis. Also involved in receptor-mediated endocytosis and membrane trafficking of recycling endosomes, probably originating from clathrin-coated vesicles. Required in a complex with MYO5B and RAB11 for the transport of NPC1L1 to the plasma membrane. Also acts as a regulator of cell polarity. Plays an essential role in phagocytosis through a mechanism involving TICAM2, RAC1 and CDC42 Rho GTPases for controlling actin-dynamics. . |
Accessions | Q7L804 ENST00000355624.8 [Q7L804-1] ENST00000369199.5 [Q7L804-2] |